MENU
+Compare
IXUS
ETF ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$84.29
Change
-$0.98 (-1.15%)
Net Assets
51.61B

IXUS stock forecast, quote, news & analysis

The investment seeks to track the investment results of the MSCI ACWI ex USA IMI composed of large-, mid- and small-capitalization non-U... Show more

IXUS
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for IXUS with price predictions
Nov 12, 2025

IXUS's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for IXUS turned positive on November 12, 2025. Looking at past instances where IXUS's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on IXUS as a result. In of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IXUS advanced for three days, in of 353 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 302 cases where IXUS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IXUS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN), Merck & Co (NYSE:MRK), Shopify Inc (NASDAQ:SHOP), PDD Holdings (NASDAQ:PDD), AT&T (NYSE:T), Boeing Company (NYSE:BA), BHP Group Limited (NYSE:BHP), Spotify Technology SA (NYSE:SPOT), Newmont Corp (NYSE:NEM), BP plc (NYSE:BP).

Industry description

The investment seeks to track the investment results of the MSCI ACWI ex USA IMI composed of large-, mid- and small-capitalization non-U.S. equities. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted market capitalization weighted index designed to measure the combined equity market performance of developed and emerging markets countries, excluding the United States.

Market Cap

The average market capitalization across the iShares Core MSCI Total Intl Stk ETF ETF is 24.96B. The market cap for tickers in the group ranges from 1.13K to 398.86B. ASML holds the highest valuation in this group at 398.86B. The lowest valued company is EXCL at 1.13K.

High and low price notable news

The average weekly price growth across all stocks in the iShares Core MSCI Total Intl Stk ETF ETF was 39%. For the same ETF, the average monthly price growth was 42%, and the average quarterly price growth was 445%. NVA experienced the highest price growth at 68%, while IRE experienced the biggest fall at -49%.

Volume

The average weekly volume growth across all stocks in the iShares Core MSCI Total Intl Stk ETF ETF was -10%. For the same stocks of the ETF, the average monthly volume growth was -8% and the average quarterly volume growth was 7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 50
Price Growth Rating: 53
SMR Rating: 65
Profit Risk Rating: 63
Seasonality Score: 15 (-100 ... +100)
View a ticker or compare two or three
IXUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category ForeignLargeBlend

Profile
Fundamentals
Details
Category
Foreign Large Blend
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com